Form 4: Guardant Health Insider Trades: Eltoukhy Acquires Shares

Guardant Health Co-CEO Helmy Eltoukhy reported transactions involving the acquisition of company stock, including shares from vested Restricted Stock Units and shares retained for tax withholding.

Summary

• Helmy Eltoukhy, Co-Chief Executive Officer and Director of Guardant Health, Inc., reported several transactions on March 31, 2026, and April 1, 2026.
• On March 31, 2026, Eltoukhy acquired 2,817 shares of Common Stock with a transaction code 'M' (conversion/exercise of derivative security) and a price of $0, representing vested Restricted Stock Units (RSUs). Additionally, 1,428 shares were disposed of with code 'F' (payment of exercise price or withholding taxes) at $92.37, also related to RSUs.
• On April 1, 2026, Eltoukhy acquired 23,997 shares and 9,716 shares of Common Stock, both with transaction code 'M' and a price of $0, indicating the vesting of RSUs. On the same day, 17,087 shares were disposed of with code 'F' at $91.15, related to tax withholding obligations upon vesting.
• Following these transactions, Eltoukhy beneficially owns 2,097,721 shares of common stock, with ownership forms listed as direct and indirect, including shares held by the Helmy A. Eltoukhy Revocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports routine insider transactions related to equity compensation and tax obligations rather than new strategic initiatives or significant changes in beneficial ownership.

Positives

• Insider acquisition of company stock by a key executive can signal confidence in the company's future prospects.
• Vesting of Restricted Stock Units indicates the achievement of performance or service conditions, potentially aligning executive interests with shareholder value.
• The retention of shares for tax withholding suggests a mechanism to manage tax liabilities associated with equity awards without immediate sale.

Negatives

• The disposal of shares for tax withholding obligations, while standard, represents a reduction in the executive's direct holdings.
• The filing does not provide details on the executive's intent behind these transactions beyond the standard explanations for RSU vesting and tax withholding.

Risks

• The filing does not explicitly mention any new or evolving risks to the company's operations or financial performance.

Future Outlook

The filing does not contain forward-looking statements or specific guidance regarding future performance.

Management Comments

• The filing includes an explanation that shares retained by the Company for tax withholding were not in excess of the tax liability.
• Explanations detail the vesting schedules for various Restricted Stock Unit awards granted to Helmy Eltoukhy.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions, are closely watched by the market as potential indicators of management's belief in the company's valuation and future growth. For a company like Guardant Health, operating in the competitive and rapidly evolving diagnostics and precision oncology space, such signals from leadership can influence investor sentiment.

Stakeholder Impact

• Shareholders: May interpret insider acquisitions as a positive signal of management's confidence in the company's long-term value.
• Employees: Vesting of RSUs can be a positive indicator for employees who also hold equity, reflecting progress towards performance or service milestones.
• Management: The transactions reflect the standard compensation and tax management practices for executives holding equity awards.

Next Steps

• Continued monitoring of insider transactions for further insights into executive confidence and potential shifts in beneficial ownership.
• Analysis of Guardant Health's upcoming financial reports and strategic updates to contextualize the significance of insider activity.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Securities Exchange Act, Helmy Eltoukhy